share_log

ProSomnus | 8-K: Current report

ProSomnus | 8-K: Current report

ProSomnus | 8-K:重大事件
SEC announcement ·  03/22 16:18
Moomoo AI 已提取核心信息
ProSomnus, Inc., a company listed on the Nasdaq Global Market under the trading symbol OSA, has reported a failure to comply with Nasdaq's minimum Market Value of Publicly Held Shares (MVPHS) requirement of $15 million as of the compliance deadline on March 18, 2024. The company received a determination letter from Nasdaq on March 19, 2024, confirming its non-compliance. ProSomnus had previously disclosed its non-compliance and its intention to appeal the delisting determination related to the Market Value of Listed Securities (MVLS) requirement. A hearing with the Nasdaq Hearings Panel has been scheduled, where ProSomnus plans to present a compliance plan addressing both the MVPHS and MVLS requirements. The company also faces non-compliance with Nasdaq's minimum bid price requirement, with...Show More
ProSomnus, Inc., a company listed on the Nasdaq Global Market under the trading symbol OSA, has reported a failure to comply with Nasdaq's minimum Market Value of Publicly Held Shares (MVPHS) requirement of $15 million as of the compliance deadline on March 18, 2024. The company received a determination letter from Nasdaq on March 19, 2024, confirming its non-compliance. ProSomnus had previously disclosed its non-compliance and its intention to appeal the delisting determination related to the Market Value of Listed Securities (MVLS) requirement. A hearing with the Nasdaq Hearings Panel has been scheduled, where ProSomnus plans to present a compliance plan addressing both the MVPHS and MVLS requirements. The company also faces non-compliance with Nasdaq's minimum bid price requirement, with a compliance period ending on April 30, 2024. ProSomnus has stated that there is no assurance that the Panel will accept its compliance plan or that the company will be able to regain compliance with Nasdaq's listing requirements. The potential delisting of ProSomnus' securities could negatively impact the ability to trade its securities, obtain accurate quotations, and could materially affect the securities' price. It may also hinder the company's ability to raise capital and trigger defaults under existing agreements.
ProSomnus, Inc. 是一家在纳斯达克全球市场上市的公司,交易代码为OSA,该公司报告称,截至2024年3月18日的合规截止日期,该公司未能遵守纳斯达克公开持股最低市值(MVPHS)的1500万美元要求。该公司于2024年3月19日收到了纳斯达克的裁决书,证实了其违规行为。ProsomNUS此前曾披露其违规行为,并打算对与上市证券市值(MVLS)要求相关的退市决定提出上诉。已计划与纳斯达克听证会小组举行听证会,ProsomNUS计划在听证会上提出一项满足MVPHS和MVLS要求的合规计划。该公司还面临不遵守纳斯达克最低出价要求的问题,合规期将于2024年4月30日结束。ProsomN...展开全部
ProSomnus, Inc. 是一家在纳斯达克全球市场上市的公司,交易代码为OSA,该公司报告称,截至2024年3月18日的合规截止日期,该公司未能遵守纳斯达克公开持股最低市值(MVPHS)的1500万美元要求。该公司于2024年3月19日收到了纳斯达克的裁决书,证实了其违规行为。ProsomNUS此前曾披露其违规行为,并打算对与上市证券市值(MVLS)要求相关的退市决定提出上诉。已计划与纳斯达克听证会小组举行听证会,ProsomNUS计划在听证会上提出一项满足MVPHS和MVLS要求的合规计划。该公司还面临不遵守纳斯达克最低出价要求的问题,合规期将于2024年4月30日结束。ProsomNus表示,无法保证专家小组会接受其合规计划,也无法保证该公司能够重新遵守纳斯达克的上市要求。ProsomNUS证券的潜在退市可能会对其证券交易、获得准确报价的能力产生负面影响,并可能对证券价格产生重大影响。它还可能阻碍公司根据现有协议筹集资金和触发违约的能力。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息